Infinity Bio Hosts Community Event for Baltimore’s Brightest Students
31 Julio 2024 - 7:30AM
Business Wire
Future scientists hail from Baltimore City’s Coppin Academy High
School
Infinity Bio, Inc., a biotechnology company specializing in
antibody reactome profiling, hosted a special community event aimed
at engaging and inspiring Baltimore children with an interest in
STEM. The event took place on July 22, 2024, at Infinity Bio’s
office and laboratory at 6200 Seaforth Street, Baltimore, MD, and
featured various activities designed to spark interest in science
and technology.
Infinity Bio, founded in 2023, focuses on leveraging its
proprietary MIPSA technology to advance antibody reactome
profiling, providing crucial insights into disease mechanisms while
advancing the development of therapeutics and diagnostics. The
company’s core technology was developed at Johns Hopkins University
in Dr. H. Benjamin Larman's Laboratory of Precision Immunology.
Students from Coppin Academy High School, operated by Coppin State
University, had the opportunity to participate in hands-on
training, meet scientists, and discover the fascinating field of
immunology. The annual event is part of Infinity Bio's ongoing
commitment to giving back to the community and supporting
educational initiatives.
Dr. Quinhon Scott, Charter School Program Manager of Coppin
State University, expressed her gratitude, stating, “We are
incredibly thankful to Infinity Bio for providing our students with
this invaluable opportunity. Events like these play a crucial role
in nurturing our students' interest in STEM and broadening their
horizons. It’s inspiring to see our students engage with
cutting-edge science and envision their futures in such a dynamic
field.”
“Empowering the next generation of scientists starts with
providing them access to resources and opportunities,” said Joy M.
Nassif, CEO of Infinity Bio. “We are thrilled to host this event in
Baltimore and to contribute to the community in a meaningful way.
Our goal is to inspire curiosity and a love for science among these
young minds.”
Larman added: “There is nothing more rewarding than passing
along my love of immunology to the next generation of biomedical
researchers. The future of human health is their hands, and so much
of human health is impacted by the immune system.”
For more information on Infinity Bio, please visit
www.infinitybio.com. To schedule interviews or to access
photos/footage from the event, contact josie@clarityqst.com.
ABOUT INFINITY BIO Infinity Bio, Inc. is a biotechnology company
that provides detailed insights into the immune system using its
proprietary antibody reactome profiling platform. The company’s
core technology comprehensively measures antibody reactivities
against all known human viruses, human proteins (autoimmunity), and
allergen proteins. Infinity Bio's MIPSA technology was developed at
Johns Hopkins University in Dr. H. Benjamin Larman's Laboratory of
Precision Immunology. It builds off of decades of work in the
fields of genomics, proteomics, immunology, and bioinformatics to
enable best-in-class data quality and cost efficiency.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240731880196/en/
Media: Josie Zohny Clarity Quest Phone: 877-887-7611 Email:
josie@clarityqst.com